Myomo, Inc. (MYO) Stock

Myomo, Inc. (MYO) is a Healthcare stock trading at $1.29 (as of 2026-06-18), with a market capitalization of $30.06M and a trailing P/E of -3.0. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Myomo, Inc. designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. Its MyoPro myoelectric-controlled upper-limb brace supports weak or paralyzed arms for functional activities and is sold to orthotics and prosthetics providers, the Veterans Health Administration, rehabilitation hospitals, and through distributors.

Valuation — source: SEC EDGAR (first-party)
Price	$1.29
Market Cap	$30.06M
P/E Ratio	-3.0
EV / EBITDA	-3.4
Price / Book	4.68
Price / Sales	1.02
DCF Value (model)	$-7.19
DCF Upside vs Price	-657.4%

Profitability & Growth — source: SEC EDGAR
Revenue (TTM)	$40.93M
Net Margin	-38.1%
Return on Equity	-167.9%
Debt / Equity	1.52
Current Ratio	2.73
Revenue Growth (YoY)	25.7%
EPS Growth (YoY)	131.3%
FCF Growth (YoY)	249.5%

Financial Health — source: SEC EDGAR
Altman Z-Score	-2.78 (distress)
Piotroski F-Score	4/9 (moderate)

Valuation vs Sector & Industry
Stock P/E	-3.0
Sector P/E (Healthcare)	21.0
Industry P/E (Medical Equipment)	31.7
vs Sector	-114.4%
vs Industry	-109.5%

Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional Holder	Rosalind Advisors, Inc. ($2.60M)
Institutional Holders Tracked	10

Company
Sector	Healthcare
Industry	Medical Equipment
CEO	Paul R. Gudonis
Employees	184
Country	US
IPO Date	2017-06-12

Related Companies (Business model: Medical Devices / Life Science Tools; 8 closest by market cap; US-domiciled)

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.